Back to VOR
MARSHALL WACE, LLP VOR Position History
Vor Biopharma Inc. • Healthcare
Quarters held
12
Latest value
$1.8M
Q2 2026
Peak value
$16.9M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $269K |
| Q1 2024 | $181K |
| Q2 2024 | $81K |
| Q3 2024 | $18K |
| Q3 2024 | $64K |
| Q4 2024 | $2K |
| Q4 2024 | $39K |
| Q1 2025 | $13K |
| Q1 2026 | $467K |
| Q1 2026 | $3.2M |
| Q1 2026 | $16.9M |
| Q2 2026 | $1.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.8M | 95.6K | — | — |
| Q1 2026 | $16.9M | 946.6K | — | — |
| Q1 2026 | $3.2M | 180.6K | — | — |
| Q1 2026 | $467K | 26.2K | — | — |
| Q1 2025 | $13K | 18.7K | — | — |
| Q4 2024 | $39K | 35.3K | — | — |
| Q4 2024 | $2K | 1.8K | — | — |
| Q3 2024 | $64K | 90.7K | — | — |
| Q3 2024 | $18K | 25.9K | — | — |
| Q2 2024 | $81K | 81.1K | — | — |
| Q1 2024 | $181K | 76.3K | — | — |
| Q1 2023 | $269K | 50.1K | — | — |